A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects
Clinical trial NCT03990688 · COMPLETED
Trial details
- NCT number
- NCT03990688
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-03
- Primary completion
- 2020-09-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.